TY - JOUR
T1 - The Effect of Canola Oil on Body Weight and Composition
T2 - A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
AU - Raeisi-Dehkordi, Hamidreza
AU - Amiri, Mojgan
AU - Humphries, Karin H.
AU - Salehi-Abargouei, Amin
N1 - Funding Information:
Supported by the Research Council of the Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Author disclosures: HR-D, MA, KHH, and AS-A, no conflicts of interest. Supplemental Tables 1–4 and Supplemental Figure 1 are available from the “Supplementary data”link in the online posting of the article and from the same link in the online table of contents at https://academic.oup.com/advances/. HR-D and MA contributed equally to this work. Address correspondence to AS-A (e-mail: [email protected]; [email protected]). Abbreviations used: ALA, α-linolenic acid; A:G, android-to-gynoid ratio; BW, body weight; CO, canola oil; HC, hip circumference; RCT, randomized controlled trial; T2DM, type 2 diabetes; WC, waist circumference; WHR, waist-to-hip ratio; WMD, weighted mean difference.
Publisher Copyright:
© 2019 American Society for Nutrition.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - A number of clinical trials have examined the effect of canola oil (CO) on body composition in recent years; however, the results have been inconsistent. The present investigation aims to examine the effect of CO on body weight (BW) and body composition using a systematic review andmeta-Analysis of controlled clinical trials. Online databases including PubMed, Scopus, and Google Scholar were searched up to February, 2018 for randomized controlled clinical trials that examined the effect of CO on anthropometric measures and body composition indexes in adults. The Cochrane Collaboration's tool was used to assess the risk of bias in individual studies. A random-effects model was used to evaluate the effect of CO consumption on several outcomes: BW, body mass index, waist circumference, hip circumference, waist-To-hip ratio, android-To-gynoid ratio, and body lean and fat mass. In total, 25 studies were included in the systematic review. The meta-Analysis revealed that CO consumption reduces BW [weighted mean difference (WMD)=?0.30 kg; 95% CI: ?0.52, ?0.08 kg, P = 0.007; n = 23 effect sizes], particularly in participants with type 2 diabetes (WMD = ?0.63 kg; 95% CI: ?1.09, ?0.17 kg, P = 0.007), in studies with a parallel design (WMD = ?0.49 kg; 95% CI: ?0.85, ?0.14 kg, P = 0.006), in nonfeeding trials (WMD = ?0.32 kg; 95% CI: ?0.55, ?0.09 kg, P = 0.006), and when compared with saturated fat (WMD = ?0.40 kg; 95% CI: ?0.74, ?0.06 kg, P = 0.019). CO consumption did not significantly affect any other anthropometric measures or body fat markers (P > 0.05). Although CO consumption results in a modest decrease in BW, no significant effect was observed on other adiposity indexes. Further well-constructed clinical trials that target BW and body composition as their primary outcomes are needed.
AB - A number of clinical trials have examined the effect of canola oil (CO) on body composition in recent years; however, the results have been inconsistent. The present investigation aims to examine the effect of CO on body weight (BW) and body composition using a systematic review andmeta-Analysis of controlled clinical trials. Online databases including PubMed, Scopus, and Google Scholar were searched up to February, 2018 for randomized controlled clinical trials that examined the effect of CO on anthropometric measures and body composition indexes in adults. The Cochrane Collaboration's tool was used to assess the risk of bias in individual studies. A random-effects model was used to evaluate the effect of CO consumption on several outcomes: BW, body mass index, waist circumference, hip circumference, waist-To-hip ratio, android-To-gynoid ratio, and body lean and fat mass. In total, 25 studies were included in the systematic review. The meta-Analysis revealed that CO consumption reduces BW [weighted mean difference (WMD)=?0.30 kg; 95% CI: ?0.52, ?0.08 kg, P = 0.007; n = 23 effect sizes], particularly in participants with type 2 diabetes (WMD = ?0.63 kg; 95% CI: ?1.09, ?0.17 kg, P = 0.007), in studies with a parallel design (WMD = ?0.49 kg; 95% CI: ?0.85, ?0.14 kg, P = 0.006), in nonfeeding trials (WMD = ?0.32 kg; 95% CI: ?0.55, ?0.09 kg, P = 0.006), and when compared with saturated fat (WMD = ?0.40 kg; 95% CI: ?0.74, ?0.06 kg, P = 0.019). CO consumption did not significantly affect any other anthropometric measures or body fat markers (P > 0.05). Although CO consumption results in a modest decrease in BW, no significant effect was observed on other adiposity indexes. Further well-constructed clinical trials that target BW and body composition as their primary outcomes are needed.
KW - Body mass index
KW - Body weight
KW - Canola oil
KW - Meta-Analysis
KW - Obesity
KW - Rapeseed oil
KW - Systematic review
UR - https://www.scopus.com/pages/publications/85066852728
U2 - 10.1093/advances/nmy108
DO - 10.1093/advances/nmy108
M3 - Review article
C2 - 30809634
AN - SCOPUS:85066852728
SN - 2161-8313
VL - 10
SP - 419
EP - 432
JO - Advances in Nutrition
JF - Advances in Nutrition
IS - 3
ER -